Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies.
Prevalence of Orthopedic Manifestations in Patients With Cardiac Amyloidosis With a Focus on Shoulder Pathologies.
复制标题
心脏淀粉样变性患者骨科表现的患病率,重点是肩部病理。
DOI:
10.1016/j.amjcard.2022.11.014
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Hanna,Mazen
中科院分区:
文献类型:
--
作者:
Basdavanos,Alyssa;Maurer,MathewS;Ives,Lauren;Derwin,Kathleen;Ricchetti,EricT;Seitz,William;Hanna,Mazen
Transthyretin cardiac amyloidosis (ATTR-CA) is a restrictive cardiomyopathy that has been associated with multiple orthopedic pathologies years before it manifests in the heart. There have been no studies on the prevalence of a wide range of shoulder pathologies in patients with cardiac amyloidosis (CA). Due to the preferential deposition of transthyretin in the soft tissues and joints, we predicted a greater prevalence of shoulder pathologies and other orthopedic manifestations in patients with ATTR-CA. This single-center, retrospective, case-control study, analyzed 1,310 patients with CA, 830 with ATTR-CA, and 480 with light-chain CA (AL-CA) from a dedicated CA REDcap database. Odds ratios comparing patients with CA to the age-matched published estimate of over 300 million patients in the general population were determined for shoulder, hip, and knee arthroplasty. Years between a patient's first shoulder pathology (i.e., shoulder arthroplasty) and the year of their diagnosis with CA were determined using data from patients with a known date of surgery. Overall, patients with ATTR-CA compared with patients with AL-CA presented more frequently with shoulder pathologies (p <0.001) and at least 1 orthopedic manifestation (p <0.001). The odds of patients with ATTR-CA and AL-CA aged 60 years or older who underwent shoulder arthroplasty was 6.05 times greater (95% confidence interval 4.26 to 8.60) and 1.63 times greater (95% confidence interval 0.67 to 3.94), respectively, compared with age-matched controls. Shoulder pathologies and concomitant orthopedic pathologies are common in patients with ATTR-CA and may help identify patients with CA earlier in their disease progression for earlier intervention and treatment.
登录
查看更多内容
影响因子:
2.7
作者:
M. L. King;E. Barklis
通讯作者:
E. Barklis
DOI:
10.1242/dev.88.1.135
发表时间:
1985
期刊:
Journal of embryology and experimental morphology
影响因子:
--
作者:
J. Cooke
通讯作者:
J. Cooke
DOI:
10.1016/0045-6039(87)90447-7
发表时间:
1987-06-01
期刊:
CELL DIFFERENTIATION
影响因子:
--
作者:
MIYATA, S;KAGEURA, H;KIHARA, HK
通讯作者:
KIHARA, HK
影响因子:
2.7
作者:
KAGEURA, H
通讯作者:
KAGEURA, H
影响因子:
2.7
作者:
Jean-Paul Vincent;John C. Gerhart
通讯作者:
Jean-Paul Vincent;John C. Gerhart